Cyagen's Neuropharmacology Platform provides comprehensive preclinical solutions designed to streamline drug discovery and development for neurological research. Our end-to-end services begin with advanced neurological disease models, offering access to a repository of over 2,000 research-ready mouse models , next-generation HUGO-GT™ humanized models , and custom model generation to meet specific study needs. The platform integrates precision drug administration services, featuring an extensive array of specialized delivery techniques for CNS therapeutics such as stereotactic brain and intrathecal injections. To complete the workflow, our integrated efficacy evaluation services combine multifunctional neurobehavioral assessments with in-depth molecular and pathological phenotype validation to thoroughly assess therapeutic outcomes.